home / stock / gene / gene news


GENE News and Press, Genetic Technologies Ltd From 07/07/22

Stock Information

Company Name: Genetic Technologies Ltd
Stock Symbol: GENE
Market: NASDAQ
Website: gtglabs.com

Menu

GENE GENE Quote GENE Short GENE News GENE Articles GENE Message Board
Get GENE Alerts

News, Short Squeeze, Breakout and More Instantly...

GENE - Longeveron, Adverum top healthcare gainers; while DiaMedica, CytomX lead losers' pack

Gainers: Longeveron ( LGVN ) +16% . Adverum Biotechnologies ( ADVM ) +13% . 89bio ( ETNB ) +12% . Mainz Biomed ( MYNZ ) +11% . Shineco ( SISI ) +8% . Losers: DiaMedica Therapeutics ( DMAC ) -41% . Cytom...

GENE - EasyDNA expands Indian and European markets; launching NIPT, Carrier testing and DNA storage

MELBOURNE, Australia, July 05, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious disease is delighted to announce the Company’s recentl...

GENE - GeneType Risk Assessment Test onboarding in 16 clinics

MELBOURNE, Australia, July 01, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious disease is delighted to announce the Company has commenced in...

GENE - Transformational Pathway to US Payer System; Attributing US$1.4 Billion Health and Economic Benefit from geneType Breast Cancer Risk Assessment Test

MELBOURNE, Australia, June 16, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious disease is delighted to announce the completion of an indepen...

GENE - Cholesterol-lowering gene changes may increase the risk of cataracts

Research Highlights: Researchers used large-scale genotyping and exome sequencing from the UK Biobank to gain insight into the expected effects of long-term statin use on cataract risk. The analysis found that common genetic variants in more than 402,000 people, who were not taking stati...

GENE - Genetec Scales New Heights with Highest Annual Profit to Date

Genetec Scales New Heights with Highest Annual Profit to Date BANGI, Malaysia, May 26, 2022 - (ACN Newswire) - Technology leader in providing fully customised, intelligent manufacturing automation solutions, Genetec Technology Berhad announced its best annual performance to da...

GENE - Acquisition of global direct to consumer ecommerce business

MELBOURNE, Australia, May 16, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious disease advises that it has entered into an agreement to acqui...

GENE - GOEV, SUNW and APPH among pre market gainers

Rattler Midstream RTLR +14% Diamondback Energy to buy Rattler Midstream in all-stock deal. Spirit Airlines SAVE +14% on new tender offer from JetBlue. AgriFORCE Growing Systems (AGRI) +15%. NanoViricides (NNVC) +14% reports that it has begun drug development to combat...

GENE - Genetic Technologies Limited (GENE) CEO Simon Morriss on Q3 2022 Results - Earnings Call Transcript

Genetic Technologies Limited (GENE) Q3 2022 Earnings Conference Call April 20, 2022, 6:00 PM ET Company Participants Simon Morriss – Chief Executive Officer Mike Tonroe – Chief Financial Officer Dr. George Muchnik – Non-Executive Director and Medical Advisor Conference Ca...

GENE - Notable earnings after Wednesday's close

AA, BDN, CCI, CSX, CVNA, EFX, FR, GENE, GL, KALU, KMI, KNX, LBRT, LRCX, LSTR, MMLP, RLI, SAND, SEIC, SLG, SNBR, STLD, THC, TSLA, UAL, UMPQ, VMI, WHR For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Wednesday's close

Previous 10 Next 10